Rupert Vessey Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 4 months, 4 weeks ago

Rupert Vessey has an estimated net worth of at least $26.6 million*, as of April 9, 2025. They own shares of BMY stock. They have sold 348,545 shares of BMY stock since 2021, for an estimated $24.1 million.

Rupert Vessey $BMY SEC Form 4 Insider Trading

Rupert Vessey has filed a total of 8 insider trades in $BMY since 2021. Their most recent trade was a sale of 50,385 shares, made on May 03, 2023. Their largest trade was a sale of 140,653 shares, made on Jul 30, 2021. We estimate that they now own shares of $BMY, worth an estimated $2.4 million.

Insider Trading at $BMY

There have been a total of 45 insider trades reported at $BMY since 2021, with 23,474 shares purchased and 1.4 million shares sold. The most active insider traders in $BMY stock have been Giovanni Caforio, Rupert Vessey, and David V Elkins. The most recent trade was a sale of 56,000 shares reported by David V Elkins (EVP, Chief Financial Officer), made on Sep 02, 2025.

History of Insider Stock Trades by Rupert Vessey

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
BMY	Sale	50,385	May 03, 2023	May 4, 2023, 5:51 p.m.
BMY	Sale	45,910	Nov 07, 2022	Nov. 9, 2022, 9:38 p.m.
BMY	Sale	31,331	Mar 16, 2022	March 18, 2022, 5:50 p.m.
BMY	Sale	43,228	Mar 16, 2022	March 18, 2022, 5:50 p.m.
BMY	Sale	6,198	Dec 16, 2021	Dec. 16, 2021, 8 p.m.
BMY	Sale	13,100	Dec 16, 2021	Dec. 16, 2021, 8 p.m.
BMY	Sale	17,740	Jul 30, 2021	Aug. 2, 2021, 8 p.m.
BMY	Sale	140,653	Jul 30, 2021	Aug. 2, 2021, 8 p.m.

$BMY Executives and Stock Owners with Insider Trades

Giovanni Caforio, Board Chair and CEO
Rupert Vessey, EVP, Research & Early Dev.
David V Elkins, EVP, Chief Financial Officer
Autenried Paul Von, EVP, Chief Information Officer
Ann Powell, EVP, Chief Human Resources
Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev.
Christopher S. Boerner, Chief Executive Officer
Sandra Leung, EVP, General Counsel
Christopher S. Boerner, EVP, Chief Commercial Officer
Benjamin Hickey, President, RayzeBio Org.
Giovanni Caforio, Chairman and CEO
Karen Murphy Santiago, SVP & Controller
Phil M Holzer, SVP and Controller
Rupert Vessey, EVP & President, Research
Bartie Wendy Short, EVP, Corporate Affairs
Robert M Plenge, EVP, Chief Research Officer
Adam Dubow, SVP,ChiefCompliance&EthicsOff.

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.